Bank Of America Corp Sonoma Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.14 - $0.26 $17 - $33	128 Added 290.91%	172 $0
Q3 2022 Nov 14, 2022	SELL	$2.18 - $43.4 $16,092 - $320,378	-7,382 Reduced 99.41%	44 $0
Q2 2022 Aug 12, 2022	BUY	$2.65 - $4.12 $19,562 - $30,413	7,382 Added 16777.27%	7,426 $21,000
Q3 2021 Nov 15, 2021	SELL	$5.23 - $8.89 $104 - $177	-20 Reduced 31.25%	44 $0
Q2 2021 Sep 13, 2021	BUY	$7.12 - $9.15 $455 - $585	64 New	64 $0

2.27K

Ticker SNOA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,100,940
Market Cap $8.87M
Description
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.